Overview
BioDiscovery Toronto is an incorporated, not-for-profit organization, facilitating the commercialization of break-through technologies. We provide industry with streamlined access to innovations and world-class research and expertise, and create new linkages among research, industry and capital.
BioDiscovery Toronto member institutions include the Centre for Addiction and Mental Health, Mount Sinai Hospital, Ontario Institute for Cancer Research, Ryerson University, St. Michael's Hospital, Sunnybrook Health Sciences Centre, The Hospital for Sick Children, Toronto Rehabilitation Institute, the University Health Network and the University of Toronto.
BioDiscovery Toronto is part of a system of Ontario regional innovation networks (RINS). These are multi-stakeholder organizations that were established by the Ontario government in 2004 to increase innovation in the Province and to foster better academic-industry partnerships globally.
Located in the Toronto Discovery District at the MaRS Convergence Centre, BioDiscovery Toronto is within walking distance of all member institutions, helping to fulfill its goal of providing a common point-of-contact to industry and the financial community to ensure that the entire technology and knowledge transfer system is effective and timely.
BioDiscovery Toronto receives its core funding from the member institutions and from the provincial Ministry of Research and Innovation's Regional Innovation Network's Program, the federal government's NSERC/CIHR Intellectual Property Mobilizations Program and the City of Toronto.